Skip to main content

CFIA-AIRS Updates September 3 2025

CFIA-AIRS Updates September 3, 2025

Chapter 30

Chapter 30 was published to add the following OGD extensions:

30.02.51.0001 – Stem cells or other cell therapy products (human)
30.02.51.1000 – Stem cells (equine)
30.02.51.2000 – Stem cells and other cell therapy products (reptile, amphibian, cetacean, pinniped, sirenian)
30.02.51.3000 – Stem cells and other cell therapy products [prairie dogs (Cynomys sp.), African Giant Pouched Rats (Cricetomys gambianus) and squirrels of the family Sciuridae]
30.02.51.9999 – Other

Mises à jour ACIA-SARI le 3 septembre 2025

Chapitre 30

Le chapitre 30 a été publié pour ajouter les prolongements AMG suivants :

30.02.51.0001 – Cellules souches ou autres produits de thérapie cellulaire (humains)
30.02.51.1000 – Cellules souches (équines)
30.02.51.2000 – Cellules souches et autres produits de thérapie cellulaire (reptiles, amphibiens, cétacés, pinnipèdes, sirénien)
30.02.51.3000 – Cellules souches et autres produits de thérapie cellulaire [chiens de prairie (Cynomys sp.), rats géants africains à poche (Cricetomys gambianus) et écureuils de la famille des Sciuridae]
30.02.51.9999 – Autres

Topic(s)

Release
System Updates/Outages & Delays at the Border
Other Government Departments (OGDs) Requirements

Information source

Canadian Food Inspection Agency (CFIA)
Disclaimer

The foregoing information is provided for informational purposes only and is not intended as, nor should it be considered, professional advice or a substitute for conducting your own thorough research and review. Before making any decisions or taking any action based on the information provided, you should conduct your own independent investigation and/or seek professional advice from a qualified expert in the relevant field. The CSCB disclaims all liability for actions taken or not taken based on the information provided.